NF-κB-mediated inhibition of histone deacetylases (HDACs), which are chromatin-remodeling enzymes, can facilitate an effective IKK inhibitor that targets a selected subgroup of CSCs in human HCC cell lines (Marquardt et al., 2015). The gene discussed is NFKB1; the disease is hepatocellular carcinoma.